twitter twitter

Bio Ascend

CME Information

ACCREDITED CONTINUING EDUCATION

JAP LOGO ICE

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Bio Ascend LLC. The University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

The University of Nebraska Medical Center designates this live activity for a maximum of 8.75 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE

As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. All faculty, planners, and others in a position to control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating all relevant financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC or Bio Ascend.

DISCLOSURES

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

  

FacultyConflicts of Interest
Cynthia Accuosti JonesEmployment: Johnson & Johnson
Julie Brahmer, MD, MScConsulting Fees: AstraZeneca and RAPT Therapeutics
Grant Funding: AstraZeneca
Suzanne Cole, MD, FACP, FASCOResearch Funding: FDA and Merck
Narjust Florez, MD, FASCOConsulting Fees: AstraZeneca, Pfizer, Regeneron, Mirati, and BMS
Research Funding: Genentech and DSI
Christine A. Garcia, MD, MPHConsultant: Pfizer
Catherine Lai, MD, MPHConsulting Fees: PDS Biotechnology
Advisor: AbbVie, BMS, Genentech, and Novartis
Reshma Mahtani, DOConsultant: Agendia, DSI, Eisai, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer, Puma, Sanofi, Stemline, and Sermonix
Ariela Marshall, MDConsultant: Cancer Expert Now/Onviv
Neha Mehta-Shah, MDGrant/Institutional Research Funding: AstraZeneca, Bristol Myers-Squibb, C4 Therapeutics, Celgene, Daiichi Sankyo, Dizal Pharmaceuticals, Genetech/Roche, Innate Pharmaceuticals, Yingli Pharmaceuticals

Advisory Board/Consultant: AstraZeneca, Johnson & Johnson/Janssen. Kyowa Hakko Kirin Co., Ltd., Pfizer, Secura Bio
Helen Moon, MDTBC
Teresa Ramirez Montagut, MD, PhDEmployment: Regeneron
Rachna Shroff, MD, MS, FASCOAdvisory Board Member: Incyte, Merck, QED Therapeutics, Server, Zymeworks Biopharm., Astellas, Duo, AstraZeneca, Boehringer Ingelheim Pharm., Clovis, Genentech, Natera

Research Funding: Pieris, QED Therapeutics, Seagen, Taiho, Bayer, BMS, IMV Inc., LOXO, Merck, Novocure, NUCANA, Bristol-Myers Squibb

Consulting Fees: SYROS, Hookipa Pharma, AbbVie
Mazie Tsang, MD, MAS, MSConsultant: Genentech

Stock Ownership: Poseida Therapeutics
Katherine Van Loon, MD, MPHResearch Funding: Natera
Ana I. Velazquez Manana, MD, MScConsulting Fees: AbbVie and Regeneron
Sue Yom, MD, PhDResearch Grant: BMS, EMD Serono, Nanobiotix

The following planning committee members have nothing to disclose:

Latifat Akintade, MD

Jordan Ciuro, MD

Devika Das, MD, MSHQS

Stephanie Barron Hall, MA

Jill Hinson

Edith A Perez, MD

Rebecca Shatsky, MD

Claire Verschraegen

Planning Committee

The following planning committee members have nothing to disclose:

UNMC: Brenda Ram, CMP, CHCP

Bio Ascend: Patti Bunyasaranand, MS; Dru Dace, PhD; Kristin Russo

How To Claim Credit

  1. CLICK HERE to complete the program evaluation
  2. After submitting the evaluation, your web browser will be redirected to a CME Request Form 3.
  3. Complete the CME Request Form in its entirety and email it to bram@unmc.edu
  4. Your CME certificate will be emailed to you within 30 days

 

For questions regarding CME credit for this activity, please contact BRAM@UNMC.EDU

We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.